Tech Company Financing Transactions

ImmunoGenetix Therapeutics Funding Round

ImmunoGenetix Therapeutics secured a $310 thousand funding round on 6/30/2011. Investors included Kansas Technology Enterprise Corporation.

Transaction Overview

Announced On
6/30/2011
Transaction Type
Venture Equity
Amount
$310,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8527 Bluejacket St.
Lenexa, KS 66214
USA
Email Address
Overview
ImmunoGenetix Therapeutics, Inc. is a biotechnology company developing advanced DNA immunotherapies for HIV infection.
Profile
ImmunoGenetix Therapeutics LinkedIn Company Profile
Social Media
ImmunoGenetix Therapeutics Company Twitter Account
Company News
ImmunoGenetix Therapeutics News
Facebook
ImmunoGenetix Therapeutics on Facebook
YouTube
ImmunoGenetix Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
James Laufenberg
  James Laufenberg LinkedIn Profile  James Laufenberg Twitter Account  James Laufenberg News  James Laufenberg on Facebook
Chief Financial Officer
David Tousley
  David Tousley LinkedIn Profile  David Tousley Twitter Account  David Tousley News  David Tousley on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2011: Replication Medical venture capital transaction
Next: 6/30/2011: Oxane Materials venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary